Dr. Johnson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000Fax+1 615-936-0605
Education & Training
Duke University HospitalResidency, Internal Medicine, 2008 - 2011
University of Alabama School of MedicineClass of 2008
Certifications & Licensure
TN State Medical License 2012 - 2026
AL State Medical License 2020 - 2020
NC State Medical License 2008 - 2011- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 245 citationsAbatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis.Joe-Elie Salem, Yves Allenbach, Aurore Vozy, Nicolas Bréchot, Douglas B. Johnson
The New England Journal of Medicine. 2019-06-12 - 761 citationsMolecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq dataFrancesca Finotello, Clemens Mayer, Christina Plattner, Gerhard Laschober, Dietmar Rieder
Genome Medicine. 2019-05-24 - 85 citationsDelayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma.Carina N. Owen, Xue Bai, T. Quah, Serigne Lo, Clara Allayous
Annals of Oncology. 2021-07-01
Journal Articles
- Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-cell PopulationsZeynep Eroglu, Iman Osman, Theodore S Nowicki, Antoni Ribas, Michael A Davies, Farbod Darvishian, Daniel Y Wang, Douglas B Johnson, Ravi K Amaravadi, Clinical Cancer Research
Press Mentions
Immunotherapy-Related Myocarditis Linked to T Cells Targeting Cardiac-Specific AntigenNovember 17th, 2022- Cardiac Antigen Identified as Mechanism for Heart Complication with Immunotherapy-Related MyocarditisNovember 16th, 2022
- Researchers Point to Toxic Side Effects of Cancer Drugs | SciencesSeptember 8th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
